Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Rare Disease Group, |
RCV000754968 | SCV000788395 | likely pathogenic | Ellis-van Creveld syndrome | 2018-05-01 | criteria provided, single submitter | research | |
Ce |
RCV002275101 | SCV002563813 | uncertain significance | not provided | 2019-01-01 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV002531369 | SCV003514003 | likely pathogenic | Ellis-van Creveld syndrome; Curry-Hall syndrome | 2023-10-08 | criteria provided, single submitter | clinical testing | This sequence change falls in intron 1 of the EVC gene. It does not directly change the encoded amino acid sequence of the EVC protein. This variant is present in population databases (rs753317536, gnomAD 0.007%). This variant has been observed in individual(s) with Ellis-van Creveld syndrome (PMID: 33875766). In at least one individual the data is consistent with being in trans (on the opposite chromosome) from a pathogenic variant. ClinVar contains an entry for this variant (Variation ID: 558765). Studies have shown that this variant is associated with altered splicing resulting in multiple RNA products (PMID: 33875766). In summary, the currently available evidence indicates that the variant is pathogenic, but additional data are needed to prove that conclusively. Therefore, this variant has been classified as Likely Pathogenic. |
Fulgent Genetics, |
RCV002531369 | SCV005658290 | likely pathogenic | Ellis-van Creveld syndrome; Curry-Hall syndrome | 2024-03-14 | criteria provided, single submitter | clinical testing |